These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20683565)

  • 1. [Indications for parathyroidectomy in renal hyperparathyroidism: comments on the significance of new therapeutics].
    Dotzenrath C
    Chirurg; 2010 Oct; 81(10):902-8. PubMed ID: 20683565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcimimetics versus parathyroidectomy: What is preferable?
    Rroji M; Spasovski G
    Int Urol Nephrol; 2018 Jul; 50(7):1271-1275. PubMed ID: 29532306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroidectomy in the Management of Secondary Hyperparathyroidism.
    Lau WL; Obi Y; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):952-961. PubMed ID: 29523679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical management of renal hyperparathyroidism].
    Lorenz K; Sekulla C; Dralle H
    Zentralbl Chir; 2013 Dec; 138 Suppl 2():e47-54. PubMed ID: 21344367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in patients with renal hyperparathyroidism requiring cinacalcet pre-operatively followed by parathyroidectomy.
    Baker D; Sevak S; Callahan RE; Czako PF; Lloyd LR; Nagar S
    Am J Surg; 2019 Jan; 217(1):146-151. PubMed ID: 29929906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.
    Soliman AR; Maamoun HA; Soliman MA; Darwish H; Elbanna E
    Rom J Intern Med; 2016 Sep; 54(3):184-189. PubMed ID: 27658167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hypercalcemia after renal transplantation.
    Torregrosa JV; Barros X
    Nefrologia; 2013 Nov; 33(6):751-7. PubMed ID: 24241361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of secondary hyperparathyroidism.
    Olson JA; Leight GS
    Adv Ren Replace Ther; 2002 Jul; 9(3):209-18. PubMed ID: 12203203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States.
    Fligor SC; Li C; Hamaguchi R; William J; James BC
    J Surg Res; 2021 Aug; 264():444-453. PubMed ID: 33848844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of calcimimetics in surgery of secondary hyperparathyroidism.
    Ruiz J; Ríos A; Rodríguez JM; Llorente S; Hernández AM; Parrilla P
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):59-61. PubMed ID: 28440773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphoria induced in dialysis providers by secondary hyperparathyroidism.
    Soomro IH; Goldfarb DS
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):9-11. PubMed ID: 25516914
    [No Abstract]   [Full Text] [Related]  

  • 16. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
    Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS
    Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Definition of hyperparathyroidism and indication for surgical therapy].
    Ziegler R
    Chirurg; 1999 Oct; 70(10):1077-81. PubMed ID: 10550336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing landscape of the treatment of hyperparathyroidism related to end-stage renal disease-can we turn the clock backward?
    Kruijff S; van der Plas WY; Dulfer RR; Vriens MR; van Ginhoven TM; Engelsman AF; Delbridge LW
    Surgery; 2019 Feb; 165(2):289-290. PubMed ID: 30266441
    [No Abstract]   [Full Text] [Related]  

  • 19. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review.
    van der Plas WY; Dulfer RR; Engelsman AF; Vogt L; de Borst MH; van Ginhoven TM; Kruijff S;
    Nephrol Dial Transplant; 2017 Nov; 32(11):1902-1908. PubMed ID: 28402557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.